Page 36 - AN-1-2
P. 36

Advanced Neurology                                             Role of Panax ginseng in neuronal complications




            Table 4. Docking scores of various compounds with   Table 5. Docking outcomes of various compounds with
            disease‑related proteins.                          disease‑related proteins.
             Receptor  Ligand  Docking  H‑bonds  H‑bonds        Receptor  Ligand
                              score                            GSTP1
            GSTP1   Gensinside  −7.63   5   GLU97, GLN64,
                                            GLY50, LYS44, and
                                            GLN50
                    Panaxydol  −6.10    2   ASN204 and
                                            TYR108                      Gensinside         Panaxydol
                    Panaxynol  −5.78    1   PRO53
                    Panaxytriol   −6.12  3  LEU52, TYR7, and
                                            PRO53
            HSP90   Gensinside  −7.15   2   GLN212 and LYS208
                    Panaxydol  −7.45    2   TRP162 and GLY135           Panaxynol          Panaxytriol
                    Panaxynol  −7.79    1   GLY35              HSP90
                    Panaxytriol   −7.21  3  GLY135, PHE138,
                                            and LEU103
            MAPK8   Gensinside  −8.00   4   ARG72, ILE148,
                                            GLY146, and
                                            PRO335
                                                                        Gensinside         Panaxydol
                    Panaxydol  −4.76    3   ILE304, ASP305, and
                                            LYS308
                    Panaxynol  −4.93    1   GLN117
                    Panaxytriol   −4.37  2  MET111 and SER34

                                                                        Panaxynol          Panaxytriol
            Nevertheless, the latter part remains to be confirmed,   MAPK8
            while the former has been subject to refutation.
            Polymorphisms in the encoding gene have been heavily
            associated  with  the  manifestation  of  several  forms  and
            types of neurodegenerative cells [45,46] . This function of the
            protein/enzyme has revealed a metabolic pathway that        Gensinside         Panaxydol
            was observed to cause neurodegeneration, with various
            members of the CYP protein family playing a significant
            part in the activation of different carcinogenic compounds,
            which can then contribute to the polymorphisms in the
                                                [47]
            genes, resulting in neurodegenerative cells . Elevated      Panaxynol          Panaxytriol
            levels of CYP1A2 have been reported to be associated with
            increased risk for many types of neurodegenerations ,
                                                        [48]
            with its gene polymorphisms altering its expression that
            subsequently influence the activation and suppression of
            signaling pathways . GSTP1 is a protein that has been
                           [49]
            reported to play an important role in the proliferation
            of cells by the action of inhibiting JNK activity, which is
            observed to be inversely associated with GSTP1 activity,
            thus linking it significantly with the development of
            neurodegenerative cells in tissues. In patients with
            neuronal damage, the production of GSTP1 is increased.
            GSTP1 reportedly targets its production, thereby acting
            as a GSTP1 target gene, associating the activity of GSTP1   Figure  4. Docking-generated complexes of proteins mitogen-activated
            in neurodegenerative as well as healthy cells in vitro [50,51] .  protein kinases-8 bonded to gensinside.




            Volume 1 Issue 2 (2022)                         7                        https://doi.org/10.36922/an.v1i2.44
   31   32   33   34   35   36   37   38   39   40   41